Fluorescein Sodium and TCA Medical Kit for Cervical Lesion Diagnosis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for diagnosing cervical cancer, such as colposcopy with acetic acid, are inefficient in distinguishing low-grade from high-grade lesions and often result in over-treatment and missed high-grade lesions, with significant scarring and cervical incompetence as complications, especially in remote areas lacking complex diagnostic facilities.

Innovation Solution

A medical kit equipped with a speculum, light source, and pre-filled containers containing normal saline, acetic acid, Lugol's iodine solution, fluorescein sodium solution, and trichloroacetic acid, allowing for visualization and treatment of neoplastic tissue using polychromatic, green, and blue light, along with trichloroacetic acid application for precise diagnosis and treatment.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If colposcopy with acetic acid is used for diagnosis, then the procedure can be performed in remote areas, but the accuracy to distinguish low-grade lesions from high-grade lesions and cancer remains low

Engineering Contradiction:
Improveportability of diagnostic procedureVSAvoidaccuracy to distinguish lesion grades
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The patent uses multiple staining agents (acetic acid for acetowhite changes, Lugol's iodine for brown staining of normal tissue, and fluorescein sodium for fluorescent green staining of abnormal tissue) that produce distinct color changes in different tissue types. This multi-color approach allows differentiation of various lesion grades based on their differential staining patterns, directly addressing the limitation of acetic acid alone in distinguishing low-grade from high-grade lesions.

Inventive Principle:
Principle #32Color changes

Solution Approach 2:

The medical kit integrates multiple diagnostic functions into a single portable system: visual inspection with acetic acid, iodine staining for glycogen detection, and fluorescein sodium for enhanced contrast of abnormal vasculature. This multi-functional approach maintains portability while significantly improving diagnostic accuracy across different lesion grades.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Reliability

If drastic treatment is recommended based on colposcopic acetic acid visualization, then advanced stage cervical neoplasia can be treated, but low-grade lesions may be over-treated and high-grade lesions may be missed

Engineering Contradiction:
Improvetreatment indication accuracyVSAvoidcervical scarring and incompetence
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The differential staining response to acetic acid, iodine, and fluorescein sodium provides a more nuanced visualization of tissue abnormalities. Low-grade lesions show different staining patterns compared to high-grade lesions and cancer, allowing physicians to differentiate between lesions requiring treatment and those that can be monitored, thereby reducing unnecessary treatments and associated complications.

Inventive Principle:
Principle #32Color changes

Solution Approach 2:

The multi-step staining process provides progressive feedback on tissue characteristics. The combination of acetowhite changes, iodine non-staining patterns, and fluorescein sodium uptake creates a comprehensive diagnostic picture that reduces misclassification of lesion severity, leading to more appropriate treatment decisions.

Inventive Principle:
Principle #23Feedback

3Device complexity

If a single staining agent is used for diagnosis, then the diagnostic procedure is simple, but the sensitivity to identify high-grade lesions is insufficient

Engineering Contradiction:
Improvenumber of staining agentsVSAvoidsensitivity to identify high-grade lesions
Core Design Contradiction:
Device complexityVSReliability

Solution Approach 1:

Each staining agent produces characteristic color changes in different tissue types: acetic acid produces acetowhite changes in abnormal tissue, iodine stains normal glycogen-containing tissue brown, and fluorescein sodium produces fluorescent green staining in areas with abnormal vasculature. The combination of these distinct color patterns significantly improves sensitivity for identifying high-grade lesions compared to any single agent alone.

Inventive Principle:
Principle #32Color changes

Solution Approach 2:

The diagnostic process is segmented into multiple staining steps, each providing specific information about tissue characteristics. This segmentation allows comprehensive assessment of lesion grade through cumulative information from different staining reactions, improving detection sensitivity while maintaining procedural organization.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enhances the ability to accurately diagnose and treat cervical intraepithelial neoplasia by visualizing abnormal tissue patterns and providing a method for precise application of trichloroacetic acid, reducing unnecessary treatments and complications while improving diagnostic accuracy in resource-limited settings.

Implementation Method 1

a fifth containing fluorescein sodium solution

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Implementation Method 2

trichloroacetic acid (TCA)-based treatment of neoplastic tissue

Methodology Applied
Scientific EffectCoagulation: Coagulation

Data Source

PatentUS10588564B2Method and kit for diagnosing and treating neoplastic tissue
Publication Date: 2020.03.17 MOEIN SUDABEH DR
  • US10588564B2 patent drawing
  • US10588564B2 patent drawing
  • US10588564B2 patent drawing

AI summary

The disclosure concerns a medical kit arranged with componentry for fluorescein sodium (FNa)-based diagnosis and trichloroacetic acid (TCA)-based treatment of neoplastic tissue, and related methods for utilizing aspects of the medical kit.